vorinostat has been researched along with Cirrhosis, Liver in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The HDAC inhibitor SAHA alleviated liver fibrosis by suppressing the TGF-β1 signaling." | 1.48 | Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway. ( Chen, Q; Gong, ZJ; Jiao, FZ; Wang, Y; Zhang, WB; Zhao, L, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özel, M | 1 |
| Baskol, M | 1 |
| Akalın, H | 1 |
| Baskol, G | 1 |
| Wang, Y | 1 |
| Zhao, L | 1 |
| Jiao, FZ | 1 |
| Zhang, WB | 1 |
| Chen, Q | 1 |
| Gong, ZJ | 1 |
2 other studies available for vorinostat and Cirrhosis, Liver
| Article | Year |
|---|---|
Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).
Topics: Actins; Cadherins; Cell Line; Cell Movement; Cell Proliferation; Collagen Type I; Collagen Type I, a | 2021 |
Histone deacetylase inhibitor suberoylanilide hydroxamic acid alleviates liver fibrosis by suppressing the transforming growth factor-β1 signal pathway.
Topics: Analysis of Variance; Animals; Biopsy, Needle; Blotting, Western; Disease Models, Animal; Histone De | 2018 |